IGC — IGC Pharma Cashflow Statement
0.000.00%
Last trade - 00:00- $28.57m
- $29.30m
- $1.27m
Annual cashflow statement for IGC Pharma, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 9 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-KT |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -15 | -11.5 | -13 | -7.12 | -4.15 |
| Depreciation | |||||
| Non-Cash Items | 4.37 | 3.01 | 5.27 | 1.78 | -1.13 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 2.54 | 0.794 | 1.89 | -0.072 | 0.228 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Cash from Operating Activities | -7.46 | -7.05 | -5.2 | -4.79 | -4.72 |
| Capital Expenditures | -0.742 | -0.619 | -0.515 | -0.482 | -0.653 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | 0 | 0.384 | 0.198 | 0.04 | 0.631 |
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Change in Net Investments | |||||
| Purchase of Investments | |||||
| Cash from Investing Activities | -0.742 | -0.235 | -0.317 | -0.442 | -0.022 |
| Financing Cash Flow Items | — | — | 0.5 | 0 | — |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 4.14 | 0.1 | 3.52 | 4.45 | 5.22 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -4.09 | -7.26 | -2 | -0.793 | 0.495 |